AstraZeneca PLC (AZN)
162.13
-0.57
(-0.35%)
USD |
NYSE |
Aug 31, 16:00
162.51
+0.38
(+0.23%)
Pre-Market: 08:57
AstraZeneca Free Cash Flow : 8.051B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | 8.051B |
| December 31, 2025 | 8.977B |
| September 30, 2025 | 9.870B |
| June 30, 2025 | 8.486B |
| March 31, 2025 | 9.455B |
| December 31, 2024 | 7.618B |
| September 30, 2024 | 7.117B |
| June 30, 2024 | 7.326B |
| March 31, 2024 | 6.098B |
| December 31, 2023 | 6.854B |
| September 30, 2023 | 7.219B |
| June 30, 2023 | 6.745B |
| March 31, 2023 | 6.155B |
| December 31, 2022 | 7.297B |
| September 30, 2022 | 6.125B |
| June 30, 2022 | 5.35B |
| March 31, 2022 | 5.18B |
| December 31, 2021 | 3.797B |
| September 30, 2021 | 4.345B |
| June 30, 2021 | 4.408B |
| March 31, 2021 | 3.938B |
| December 31, 2020 | 2.24B |
| September 30, 2020 | 1.993B |
| June 30, 2020 | 1.667B |
| March 31, 2020 | 1.535B |
| Date | Value |
|---|---|
| December 31, 2019 | 633.00M |
| September 30, 2019 | 1.483B |
| June 30, 2019 | 916.00M |
| March 31, 2019 | 770.00M |
| December 31, 2018 | 1.437B |
| September 30, 2018 | 72.05M |
| June 30, 2018 | 1.775B |
| March 31, 2018 | 1.930B |
| December 31, 2017 | 2.122B |
| September 30, 2017 | 2.984B |
| June 30, 2017 | 1.532B |
| March 31, 2017 | 791.57M |
| December 31, 2016 | 1.964B |
| September 30, 2016 | 666.51M |
| June 30, 2016 | 1.440B |
| March 31, 2016 | 2.686B |
| December 31, 2015 | 659.00M |
| September 30, 2015 | 2.019B |
| June 30, 2015 | 2.331B |
| March 31, 2015 | 2.848B |
| December 31, 2014 | 4.446B |
| September 30, 2014 | 4.753B |
| June 30, 2014 | 3.878B |
| March 31, 2014 | 4.146B |
| December 31, 2013 | 5.429B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GSK Plc | 6.621B |
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
| Novo Nordisk A/S | 7.517B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.420B |
| Cash from Investing (Quarterly) | -1.856B |
| Cash from Financing (Quarterly) | 266.55M |
| Free Cash Flow Per Share (Quarterly) | 0.6037 |
| Free Cash Flow to Equity (Quarterly) | -2.411B |
| Free Cash Flow to Firm (Quarterly) | 2.194B |
| Free Cash Flow Yield | 1.59% |